614 A randomised clinical trial of 89 strontium and the aminobisphosphonate olpadronate in the palliative management of hormone refractory metastatic prostate cancer: Comparative efficacy and cost analysis

Authors :: R.C.M. Pelger
A. H. Zwinderman
N. Hamdy
B. Van Eck
V. Soerdjbalie-Maikoe
G. Lycklama-Nijeholt
S. Papapoulos
W. Van den Hout
Source :: European Urology Supplements. 3:156
Publication Year :: 2004
Publisher :: Elsevier BV, 2004.

Subjects :: Oncology
Clinical trial
medicine.medical_specialty
Prostate cancer
Hormone refractory
Olpadronate
business.industry
Urology
Internal medicine
Cost analysis
Medicine
business
medicine.disease

Tools